Form 4: HCSG CEO Theodore Wahl Increases Stake Through Equity Awards
Insider Transaction Report
Healthcare Services Group CEO Theodore Wahl reported significant increases in his beneficial ownership of company stock through an employee stock purchase plan and vesting of restricted stock units.
Summary
- Theodore Wahl, President & CEO and Director of HEALTHCARE SERVICES GROUP INC (HCSG), reported changes in his beneficial ownership of company securities.
- Wahl acquired 2,145 shares of Common Stock at $9.88 per share through the Employee Stock Purchase Plan on December 31, 2025.
- He also acquired 2,788 shares of Phantom Stock at $19.12 per share on December 31, 2025, through the Deferred Compensation Plan, which are payable upon termination of employment.
- Multiple tranches of Restricted Stock Units (RSUs) vested and converted into Common Stock, totaling 84,801 shares across various dates in January 2026.
- A disposition of 35,450 shares of Common Stock occurred on January 4, 2026, likely related to tax withholding upon RSU vesting.
- Following these transactions, Wahl's total direct beneficial ownership of Common Stock is 486,863 shares, with a total direct and indirect beneficial ownership of 604,211 shares.
Sentiment
Score: 7
Explanation: The filing indicates a net increase in the CEO's beneficial ownership through direct purchases and vesting of equity awards, which is generally viewed as a positive signal of management confidence and alignment with shareholder interests, despite a disposition likely for tax purposes.
Positives
- The CEO acquired 2,145 shares of Common Stock through the Employee Stock Purchase Plan, demonstrating continued investment in the company.
- Significant vesting of Restricted Stock Units (84,801 shares) and acquisition of Phantom Stock (2,788 shares) indicate a substantial portion of the CEO's compensation is tied to company performance and long-term value creation.
- The total direct and indirect beneficial ownership of 604,211 shares by the CEO signals strong alignment of management interests with shareholder interests.
Negatives
- A disposition of 35,450 shares of Common Stock occurred, which, while likely for tax purposes related to equity vesting, represents a reduction in direct share count.
Future Outlook
The reporting person has significant Restricted Stock Units (93,693 shares granted on January 5, 2026) that will vest at a rate of 20% annually, commencing on the first anniversary of the grant date, indicating future increases in beneficial ownership tied to continued employment and performance.
Industry Context
This Form 4 filing reflects routine insider transactions related to executive compensation and employee stock plans. It does not provide specific insights into broader industry trends for healthcare services, but rather details an executive's personal investment and compensation structure within HEALTHCARE SERVICES GROUP INC.
Related Party Transactions
- Acquisition of Common Stock through the Healthcare Services Group, Inc. Employee Stock Purchase Plan.
- Acquisition of Phantom Stock pursuant to an Issuer contribution under the Healthcare Services Group, Inc. Deferred Compensation Plan.
- Vesting and conversion of Restricted Stock Units granted by the Issuer as part of executive compensation.
Stakeholder Impact
- Shareholders: Increased insider ownership can be seen as a positive signal, indicating management's confidence in the company's future performance and aligning their interests with those of other shareholders.
- Employees: The Employee Stock Purchase Plan (ESPP) allows employees, including the CEO, to acquire company stock, fostering a sense of ownership and shared success.
Next Steps
- Continued vesting of the 93,693 Restricted Stock Units granted on January 5, 2026, at 20% annually, starting from the first anniversary of the grant date.
- Phantom Stock shares will be payable in-kind following the termination of the Reporting Person's employment with the Issuer.
Key Dates
| Date | Description |
|---|---|
| January 4, 2021 | Grant date for Restricted Stock Units, vesting at 20% annually. |
| January 4, 2022 | Grant date for Restricted Stock Units, vesting at 20% annually. |
| January 3, 2024 | Grant date for Restricted Stock Units, vesting at 20% annually. |
| January 3, 2025 | Grant date for Restricted Stock Units, vesting at 20% annually. |
| January 6, 2025 | Date of signature by Michael Harrity, by Power of Attorney. |
| December 31, 2025 | Transaction date for acquisition of 2,145 Common Stock shares via ESPP and 2,788 Phantom Stock shares. |
| January 3, 2026 | Transaction date for vesting of 30,643 and 27,842 Restricted Stock Units. |
| January 4, 2026 | Transaction date for vesting of 10,024 and 16,292 Restricted Stock Units, and disposition of 35,450 Common Stock shares. |
| January 5, 2026 | Grant date for 93,693 Restricted Stock Units, vesting at 20% annually. |
Keywords
HCSG, Healthcare Services Group, Theodore Wahl, Insider Trading, Form 4, Executive Compensation, Stock Ownership, Restricted Stock Units, Employee Stock Purchase Plan, Phantom Stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.